Publication | Open Access

The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-δ dependent manner

InflammationTumor BiologyAnti-inflammatoryCytotoxic NeutrophilsPkc-δ Dependent MannerMedicineImmunologyTumor ImmunityEndothelial DysfunctionImmune SurveillanceVascular BiologyAnti-cancer AgentPharmacologyAnti-tumor AgentCancer Research